Deutsche Bank
HARP

Deutsche Bank’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Deutsche Bank’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,072
Closed -$53K – 4401
2022
Q1 		$53K Sell
1,072
-120
-10% -$6.22K ﹤0.01% 3832
2021
Q4 		$90K Buy
1,192
+59
+5% +$4.03K ﹤0.01% 3750
2021
Q3 		$89K Sell
1,133
-677
-37% -$68.1K ﹤0.01% 3942
2021
Q2 		$251K Buy
1,810
+256
+16% +$48.8K ﹤0.01% 3655
2021
Q1 		$325K Buy
1,554
+105
+7% +$21K ﹤0.01% 3367
2020
Q4 		$241K Buy
1,449
+855
+144% +$132K ﹤0.01% 3370
2020
Q3 		$101K Buy
594
+50
+9% +$7.21K ﹤0.01% 3545
2020
Q2 		$90K Buy
544
+314
+137% +$49K ﹤0.01% 3491
2020
Q1 		$26K Sell
230
-166
-42% -$23.3K ﹤0.01% 3840
2019
Q4 		$57K Buy
396
+189
+91% +$28.7K ﹤0.01% 3909
2019
Q3 		$27K Sell
207
-252
-55% -$35.4K ﹤0.01% 4221
2019
Q2 		$58K Buy
459
+143
+45% +$16.6K ﹤0.01% 4460
2019
Q1 		$28K Buy
+316
New +$41.5K ﹤0.01% 4726

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank's HARP Position: Q2 2022 in Review

Deutsche Bank sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q2 2022, closing a stake of 1,072 shares — an estimated $53K sold.

Deutsche Bank first reported a position in HARP in Q1 2019 and held it in 13 quarters. The position peaked at $325K in Q1 2021. 63 funds tracked by Wall St. Rank hold HARP as of Q2 2022.

  • Deutsche Bank reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Deutsche Bank sold 1,072 Harpoon Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $53K.
  • Deutsche Bank first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2019 and held it in 13 quarters.
  • Deutsche Bank's Harpoon Therapeutics, Inc. Common Stock position peaked at $325K in Q1 2021.
  • 63 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.